Stifel analyst Paul Matteis reiterated a Buy rating and $166.00 price target on Neurocrine Bio. (NASDAQ: NBIX).The analyst commented, "Overall ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE